Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts

Journal of Periodontal Research

Volumn 39, Issue 5, 2004, Pages 300-307

  Yun, Jeong Ho ^a   Pang, Eun Kyoung ^a   Kim, Chang Sung ^a   Yoo, Yun Jung ^a   Cho, Kyoo Sung ^a,b   Chai, Jung Kiu ^a   Kim, Chong Kwan ^a,b   Choi, Seong Ho ^a,b  

^a Yonsei University College of Dentistry   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

( ) epigallocatechin gallate; Matrix metalloproteinase; Osteoblast; Osteoclast

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGENASE 3; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; MESSENGER RNA; POLYPHENOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; MORPHOGENESIS; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TEA; ULTRASOUND;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; CATECHIN; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED ICR; OSTEOBLASTS; OSTEOCLASTS; PLANT EXTRACTS; PORPHYROMONAS GINGIVALIS; PROTEASE INHIBITORS; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TEA;

EID: 4644293540     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00743.x     Document Type: Article

References (56)

1. Schwartz Z, Goultschin J, Dean DD, Boyan BD. Mechanisms of alveolar bone destruction in periodontitis. Periodontol 2000 1997;14:158-172.
2. Baron R. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 1989;224:317-324.
3. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989;245:855-857.
4. Chambers TJ, Darby JA, Fuller K. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tiss Res 1985;241:671-675.
5. Chambers TJ, Fuller K. Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 1985;76:155-165.
6. Delaissé JM, Engsig MT, Everts V et al. Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta 2000;291:223-234.
7. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484.
8. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994;8:312-319.
9. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997;14:144-157.
10. Heath JK, Atkinson SJ, Meikle MC, Reynolds JJ. Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim Biophys Acta 1984;802: 151-154.
11. Meikle MC, Bord S, Hembry RM, Compston J, Croucher PI, Reynolds JJ. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci 1992;103:1093-1099.
12. Hill PA, Docherty AJ, Bottomley KM et al. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 1995;308:167-175.
13. Kusano K, Miyaura C, Inada M et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 1998;139:1338-1345.
14. Mizutani A, Sugiyama I, Kuno E, Matsunaga S, Tsukagoshi N. Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res 2001;16:2043-2049.
15. Moore WE. Microbiology of periodontal disease. J Periodont Res 1987;22:335-341.
16. Slots J, Listgarten MA. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 1988;15:85-93.
17. Dzink JL, Socransky SS, Haffajee AD. The predominant cultivale microbiota of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988;15:316-323.
18. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
19. Uitto VJ, Larjava H, Heino J, Sorsa T. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun 1989;57:213-218.
20. Sorsa T, Ingman T, Suomalainen K et al. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun 1992;60:4491-4495.
21. Fravalo P, Ménard C, Bonnaure-Mallet M. Effect of Porphyromonas gingivalis on epithelial cells MMP-9 type IV collagenase production. Infect Immun 1996;64: 4940-4945.
22. DeCarlo AA, Windsor LJ, Bodden MK, Birkedal-Hansen B, Birekdal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res 1997;76:1260-1270.
23. Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodont Res 2002;37:196-203.
24. Grayson R, Douglas CW, Heath J, Rawlinson A, Evans GS. Activation of human matrix metalloproteinase 2 by gingival crevicular fluid and Porphyromonas gingivalis. J Clin Periodontol 2003;30:542-550.
25. Pattamapun K, Tiranathanagul S, Yongchaitrakul T, Kuwatanasuchat J, Pavasant P. Activation of MMP-2 by Porphyromonas gingivalis in human periodontal ligament cells. J Periodont Res 2003;38:115-121.
26. Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993;85:1038-1049.
27. Makimura M, Hirasawa M, Kobayashi K et al. Inhibitory effect of tea catechins on collagenase activity. J Periodontol 1993;64:630-636.
28. Garbisa S, Biggin S, Cavallarin N, Sartor L, Benelli R, Albini A. Tumor invasion: molecular shears blunted by green tea. Nat Med 1999;4:1216.
29. Demeule M, Brossard M, Page M, Gingras D, Beliveau R. Matrix metalloproteinase inhibition by green tea cathechins. Biochim Biophys Acta 2000;1478: 51-60.
30. Isemura M, Saeki K, Minami T et al. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Ann N Y Acad Sci 1999;878:629-631.
31. Maeda-Yamamoto M, Suzuki N, Sawai Y et al. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J Agric Food Chem 2003;51:1858-1863.
32. Nakagawa H, Wachi M, Woo JT et al. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 2002;288: 142-150.
33. 3 in osteoclast differentiation and function. Meth Enzymol 1997;282:223-235.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983;65:55-63.
35. Mallet F, Oriol G, Mary C, Verrier B, Mandrand B. Continuous RT-PCR using AMV-RT and Taq DNA polymerase: characterization and comparison to uncoupled procedures. Biotechniques 1995;18:678-687.
36. Choi BK, Ohk SH, Lee HJ, Kang JH, Jeong GJ, Yoo YJ. Effects of whole cell sonicates of Treponema lecithinolyticum on osteoclast differentiation. J Periodontol 2001;72:1172-1177.
37. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-290.
38. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-350.
39. Krahwinkel T, Willershausen B. The effect of sugar-free green tea chew candies on the degree of inflammation of the gingiva. Eur J Med Res 2000;30:463-467.
40. Millar SJ, Goldstein EG, Levine MJ, Hausmann E. Modulation of bone metabolism by two chemically distict lipopolysaccharide fractions from Bacteroides gingivalis. Infect Immun 1986;51:302-306.
41. Bom-van Noorloos AA, van der Meer JW, van de Gevel JS, Schepens E, van Steenbergen TJ, Burger EH. Bacteroides gingivalis stimulates bone resorption via interleukin-1 production by mononuclear cells. J Clin Periodontol 1990;17:409-413.
42. Loomer PM, Sigusch B, Sukhu B, Ellen RP, Tenenbaum HC. Direct effects of metabolic products and sonicated extracts of Porphyromonas gingivalis 2561 on osteogenesis in vitro. Infect Immun 1994;62:1289-1297.
43. Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 1999;67:2841-2846.
44. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 2002;70:3143-3148.
45. Uchida M, Shima M, Shimoaka T et al. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol 2000;185:207-214.
46. Gum R, Wang H, Lengyel E, Juarez J, Boyd D. Regulation of 92kDa type □ collagenase expression by the jun amino-terminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 1997;14:1481-1493.
47. Lim M, Martinez T, Jablons D et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998;441:88-92.
48. McCawley LJ, Li S, Wattenberg EV, Hudson LG. Sustained activation of the mitogen-activated protein kinase pathway. J Biol Chem 1999;274:4347-4353.
49. Reddy KB, Krueger JS, Kondapaka SB, Diglio CA. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelical cells. Int J Cancer 1999;82: 268-273.
50. Chung JY, Park JO, Phyu H, Dong Z, Yang CS. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J 2001;15:2022-2024.
51. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phophorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 2001;176:110-117.
52. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Mechanism of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 1997;88:639-643.
53. Yang G, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611-616.
54. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3 gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997;89:1881-1886.
55. Paschka AG, Butler R, Young CY. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3 gallate. Cancer Lett 1998;130:1-7.
56. 3H] (-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998;19:1771-1776.